stars 1 stars 2 stars 3

Founded in 2005, Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures. Apollo's products include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. Apollo's common stock is traded on Nasdaq Global Market under the symbol "APEN". Apollo Endosurgery, Inc. is headquartered out of Austin, Texas.

Orbera Questions

The Orbera annual revenue was $18.9 million in 2026.

Orbera is based in Winston Salem, North Carolina.

The NAICS codes for Orbera are [81, 812].

The SIC codes for Orbera are [8099, 809, 80].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users